LDHA and glioblastoma: Functional studies demonstrated that EMφ CM treatment upregulates LDHA levels in glioblastoma cells, and this effect is abolished when EMφ were pretreated with EV biogenesis inhibitor, LDHA inhibitor, or harboring LDHA knockdown/KO, suggesting that LDHA can be transferred from EMφ to glioblastoma cells.